z-logo
Premium
Protective role of IFN‐γ in collagen‐induced arthritis conferred by inhibition of mycobacteria‐induced granulocyte chemotactic protein‐2 production
Author(s) -
Kelchtermans Hilde,
Struyf Sofie,
De Klerck Bert,
Mitera Tania,
Alen Marijke,
Geboes Lies,
Van Balen Maarten,
Dillen Chris,
Put Willy,
Gysemans Conny,
Billiau Alfons,
Van Damme Jo,
Matthys Patrick
Publication year - 2007
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0806486
Subject(s) - biology , chemokine , immunology , arthritis , chemotaxis , granulocyte , inflammation , pathogenesis , interferon gamma , receptor , cytokine , biochemistry
Mice with a disrupted IFN‐γ system are remarkably susceptible to experimental autoimmune diseases, such as collagen‐induced arthritis (CIA), which rely on the use of CFA. The inflammatory lesions of these IFN‐γ knockout (KO) mice are characterized by an excessive proportion of neutrophils. Here, we show that the increased severity of CIA in IFN‐γR KO as compared with wild‐type mice is accompanied by increased levels of the CXC chemokine granulocyte chemotactic protein‐2 (GCP‐2), a major neutrophil‐attracting chemokine in mice. We demonstrated that the heat‐killed mycobacteria present in CFA elicited production of GCP‐2 in mouse embryo fibroblast cultures and that this production was inhibited by IFN‐γ. Inhibition of GCP‐2 production by IFN‐γ was STAT‐1‐dependent. IFN‐γ receptor KO mice treated with neutralizing anti‐GCP‐2 antibodies were protected from CIA, indicating the in vivo importance of GCP‐2 in the pathogenesis of CIA. Our data support the notion that one of the mechanisms whereby endogenous IFN‐γ mitigates the manifestations of CIA consists of inhibiting production of GCP‐2, thereby limiting mobilization and infiltration of neutrophils, which are important actors in joint inflammation. These results may also be applicable to other experimental models of autoimmunity that rely on the use of CFA.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here